Aethlon Medical (AEMD) to Release Earnings on Thursday

Aethlon Medical (NASDAQ:AEMDGet Free Report) is anticipated to announce its Q4 2025 earnings results before the market opens on Thursday, June 26th. Analysts expect the company to announce earnings of ($0.13) per share for the quarter.

Aethlon Medical Stock Down 11.4%

Shares of NASDAQ AEMD opened at $1.40 on Tuesday. The firm has a fifty day simple moving average of $2.76 and a 200 day simple moving average of $3.80. Aethlon Medical has a twelve month low of $1.40 and a twelve month high of $8.44. The company has a market capitalization of $2.81 million, a PE ratio of -0.11 and a beta of 1.89.

Wall Street Analyst Weigh In

AEMD has been the subject of a number of research analyst reports. Wall Street Zen initiated coverage on Aethlon Medical in a report on Thursday, May 15th. They issued a “sell” rating for the company. HC Wainwright reiterated a “buy” rating and issued a $56.00 price objective on shares of Aethlon Medical in a research note on Monday, March 10th.

View Our Latest Research Report on Aethlon Medical

About Aethlon Medical

(Get Free Report)

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.

Read More

Earnings History for Aethlon Medical (NASDAQ:AEMD)

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.